Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 28 studies | 44% ± 22% | |
astrocyte | 12 studies | 34% ± 17% | |
mesothelial cell | 8 studies | 49% ± 18% | |
ciliated cell | 8 studies | 39% ± 18% | |
endothelial cell | 7 studies | 28% ± 8% | |
glutamatergic neuron | 7 studies | 37% ± 21% | |
adipocyte | 5 studies | 28% ± 5% | |
GABAergic neuron | 5 studies | 30% ± 11% | |
smooth muscle cell | 5 studies | 46% ± 19% | |
connective tissue cell | 5 studies | 34% ± 12% | |
epithelial cell of proximal tubule | 4 studies | 53% ± 28% | |
kidney loop of Henle epithelial cell | 4 studies | 55% ± 30% | |
cholangiocyte | 3 studies | 84% ± 7% | |
glial cell | 3 studies | 19% ± 3% | |
adventitial cell | 3 studies | 50% ± 17% | |
chondrocyte | 3 studies | 38% ± 6% | |
myofibroblast cell | 3 studies | 28% ± 14% | |
pericyte | 3 studies | 20% ± 3% | |
interneuron | 3 studies | 41% ± 14% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 73% ± 30% | |
parietal epithelial cell | 3 studies | 77% ± 20% | |
renal principal cell | 3 studies | 67% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 4314.00 | 89 / 89 | 93% | 79.22 | 835 / 901 |
pancreas | 100% | 2681.65 | 328 / 328 | 91% | 25.90 | 162 / 178 |
breast | 100% | 2596.49 | 458 / 459 | 78% | 10.76 | 876 / 1118 |
prostate | 93% | 960.08 | 228 / 245 | 79% | 8.92 | 399 / 502 |
lung | 99% | 1623.30 | 573 / 578 | 67% | 8.22 | 774 / 1155 |
ovary | 100% | 2952.62 | 180 / 180 | 44% | 3.99 | 188 / 430 |
uterus | 99% | 1258.31 | 168 / 170 | 39% | 4.80 | 181 / 459 |
intestine | 89% | 984.49 | 863 / 966 | 45% | 5.48 | 239 / 527 |
bladder | 90% | 1035.71 | 19 / 21 | 44% | 4.41 | 222 / 504 |
skin | 96% | 3252.68 | 1736 / 1809 | 35% | 3.01 | 167 / 472 |
thymus | 98% | 1376.63 | 639 / 653 | 26% | 2.12 | 156 / 605 |
esophagus | 76% | 1336.88 | 1099 / 1445 | 45% | 4.83 | 82 / 183 |
adrenal gland | 95% | 1057.67 | 245 / 258 | 23% | 1.60 | 52 / 230 |
stomach | 50% | 542.53 | 180 / 359 | 58% | 6.99 | 166 / 286 |
adipose | 100% | 2917.96 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2249.88 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 93% | 1201.86 | 750 / 803 | 0% | 0 | 0 / 0 |
heart | 90% | 1400.59 | 772 / 861 | 0% | 0 | 0 / 0 |
liver | 24% | 155.96 | 55 / 226 | 51% | 21.83 | 209 / 406 |
spleen | 44% | 260.06 | 105 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 36% | 2.33 | 16 / 45 |
brain | 12% | 57.73 | 311 / 2642 | 16% | 1.29 | 112 / 705 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.45 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001822 | Biological process | kidney development |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0007507 | Biological process | heart development |
GO_0007368 | Biological process | determination of left/right symmetry |
GO_0005737 | Cellular component | cytoplasm |
GO_0003723 | Molecular function | RNA binding |
Gene name | BICC1 |
Protein name | Protein bicaudal C homolog 1 (Bic-C) BicC family RNA binding protein 1 |
Synonyms | |
Description | FUNCTION: Putative RNA-binding protein. Acts as a negative regulator of Wnt signaling. May be involved in regulating gene expression during embryonic development. . |
Accessions | A6NGY7 Q9H694 ENST00000263103.1 ENST00000373886.8 [Q9H694-1] |